105.25 -1.65 (-1.54%)

162.47% Gain from 52W Low

294.5K Volume High vol. this week

NSENov 27, 2020 03:31 PM



Shalby Ltd.    
12 Oct 2020
105.25
-1.54%
Business Line
Revenues show smart recovery over lockdown period in Q1
Shalby Ltd. is trading above all available SMAs
Shalby Ltd.    
10 Dec 2019
105.25
-1.54%
buy
ICICI Securities Limited
The company has a strong brand equity mainly in Gujarat. Shalby has witnessed significant growth in volumes across its hospital network. Arthroplasty continues to dominate its revenue pie although it has been witnessing greater traction in other specialities as well. Leverage free balance sheet, strong margins and continuous generation of free cash flows also provide additional cushion in a capex heavy industry. However, margins are still skewed towered the top two hospitals. We initiate Shalby with HOLD recommendation mainly due to high concentration risk. We value...
Shalby Ltd. has an average target of 110.00 from 1 broker.
Shalby Ltd.    
06 Feb 2018
105.25
-1.54%
Business Line
Shalby Hospitals (Shalby Ltd) has launched a radiotherapy centre at its recently-commissioned Naroda Shalby Hospital for treatment of cancer patients. Naroda Shalby, 267-bed capaci
Shalby Ltd. has an average target of 110.00 from 1 broker.
Shalby Ltd.    
15 Dec 2017
105.25
-1.54%
Economic Times
There are enough hospitals where prices are driven by competition rather than capping.
1 Comment
16 Dec 2017  Like
Shalby Ltd. has gained 76.00% in the last 6 Months
Shalby Ltd.    
15 Dec 2017
105.25
-1.54%
Shalby Hospitals debuts lower than IPO price

Shalby Hospitals made its stock market debut at a discount of 4.4%, at Rs 237 per share on the BSE compared to its issue price of Rs 248 apiece. The share price has recovered somewhat since the debut. 

The Ahmedabad-based hospital had seen lukewarm demand for its Rs 504 crore initial public offering, which was subscribed 1.08 times by the final day. The company sold shares at Rs 245-248 apiece via the IPO, valuing it around Rs 2,680 crore. Shalby is the market leader for joint replacement surgery procedures, with a 15% market share of all such surgeries conducted by private corporate hospitals in India. However a recent ruling setting a price ceiling for knee implants is likely to impact revenues for the firm in the coming quarters.

Shalby said that it plans to use the proceeds from the share sale for bringing down debt, purchase of medical equipment for the existing and recently set-up as well as upcoming hospitals.

Shalby Ltd.    
14 Dec 2017
105.25
-1.54%
Business Line
Multi-specialty hospital chain Shalby Ltd, which recently concluded its Rs 504-crore initial public offering, will list its shares on the exchanges tomorrow. The equity shares will be listed on the...
Shalby Ltd. has gained 76.00% in the last 6 Months
Shalby Ltd.    
05 Dec 2017
105.25
-1.54%
Ashika Research
60 Equity Shares and in multiples thereof. Public issue of 20,354,839 Equity shares of Face value Rs. RII 10 each, (Comprising of fresh issue of 19,354,839 Equity Total Public...
Shalby Ltd. average weekly volume is high.
Shalby Ltd.    
05 Dec 2017
105.25
-1.54%
Angel Broking
Outlook and valuation: At the upper end of the price band (`245-`248), the issue is priced at 42.8x of its FY2017 earnings vs. Apollo hospitals (73.7x) and Healthcare Global (121.2x). On EV per bed, it is available on 3.8x vs Apollo (2.3x) and Healthcare Global at 2.1x. We like its growth story, better returns profile than peers and stron..
Shalby Ltd. average weekly volume is high.
Shalby Ltd.    
04 Dec 2017
105.25
-1.54%
ICICI Securities Limited
Ahmedabad headquartered Shalby Ltd (Shalby) is a leading multispecialty chain of hospitals in India with specific focus on joint replacement. The company provides healthcare services through a network of 11 operational hospitals with an aggregate bed capacity of 2012 beds and an operational bed count of 841 beds. The company claims 15% market share of all joint replacement surgeries conducted by private corporate hospitals (organised pie) in India in 2016 (source: F&S; Report). The company also provides outpatient services through 47 outpatient clinics and has 10 shared surgery centres within third party...
Shalby Ltd. has an average target of 110.00 from 1 broker.
  • Month Change by 23.15% (Crossed threshold 20%) on 24 November, 2020
  • Week Change by 21.88% (Crossed threshold 20%) on 24 November, 2020
  • Stock Price (97.75) crossed above 30 Day SMA (92.43) on 20 November, 2020
  • Day volume (4165998.0) was 660% of the Month Average Volume (630575.0) on 13 October, 2020
  • Stock Price (85.6) crossed above 50 Day SMA (80.16) on 29 September, 2020
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Sept. 4, 20200.50FINAL-
Aug. 16, 20190.50FINAL-
All dividends by SHALBY